Form CORRESP - Correspondence:
SEC Accession No. 0001628280-17-012407
Filing Date
2017-12-18
Accepted
2017-12-18 19:45:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 25185
  Complete submission text file 0001628280-17-012407.txt   26043
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations